Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgitte Giersing

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Vaccine|April 3, 2017
Exploring new packaging and delivery options for the immunization supply chainDarin Zehrung, Courtney Jarrahian, Birgitte Giersing, et al.
Current Opinion in Molecular Therapeutics|March 3, 2007
Malaria vaccines: are we getting closer?Judith E Epstein, Birgitte Giersing, Gregory Mullen, et al.
Vaccine|July 3, 2019
Potential use of microarray patches for vaccine delivery in low- and middle- income countriesNicolas Peyraud, Darin Zehrung, Courtney Jarrahian, et al.
Vaccine|July 16, 2023
Vaccine Value ProfilesBirgitte Giersing, Ruth Karron, Marta Tufet-Bayona, et al.
Vaccine|June 24, 2015
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015Kayvon Modjarrad, Birgitte Giersing, David C Kaslow, et al.
Vaccine|November 10, 2023
Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting reportPierre-Stéphane Gsell, Birgitte Giersing, Sami Gottlieb, et al.
BMC Medicine|July 3, 2023
The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-makingRaymond Hutubessy, Jeremy A Lauer, Birgitte Giersing, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 19, 2026
Leveraging vaccine policy and investments for the AMR challengeNidhee Jadeja, Mateusz Hasso-Agopsowicz, Marta Urrutxi Gallastegi, et al.
Vaccine|March 21, 2019
End-user acceptability study of the nanopatch™; a microarray patch (MAP) for child immunization in low and middle-income countriesElise Guillermet, Daleb Abdoulaye Alfa, Le Thi Phuong Mai, et al.
Infection and Immunity|October 10, 2007
In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunizedKazutoyo Miura, Hong Zhou, Olga V Muratova, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Vaccine|April 3, 2017
Exploring new packaging and delivery options for the immunization supply chainDarin Zehrung, Courtney Jarrahian, Birgitte Giersing, et al.
Current Opinion in Molecular Therapeutics|March 3, 2007
Malaria vaccines: are we getting closer?Judith E Epstein, Birgitte Giersing, Gregory Mullen, et al.
Vaccine|July 3, 2019
Potential use of microarray patches for vaccine delivery in low- and middle- income countriesNicolas Peyraud, Darin Zehrung, Courtney Jarrahian, et al.
Vaccine|July 16, 2023
Vaccine Value ProfilesBirgitte Giersing, Ruth Karron, Marta Tufet-Bayona, et al.
Vaccine|June 24, 2015
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015Kayvon Modjarrad, Birgitte Giersing, David C Kaslow, et al.
Vaccine|November 10, 2023
Key considerations for the development of novel mRNA candidate vaccines in LMICs: A WHO/MPP mRNA Technology Transfer Programme meeting reportPierre-Stéphane Gsell, Birgitte Giersing, Sami Gottlieb, et al.
BMC Medicine|July 3, 2023
The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-makingRaymond Hutubessy, Jeremy A Lauer, Birgitte Giersing, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|February 19, 2026
Leveraging vaccine policy and investments for the AMR challengeNidhee Jadeja, Mateusz Hasso-Agopsowicz, Marta Urrutxi Gallastegi, et al.
Vaccine|March 21, 2019
End-user acceptability study of the nanopatch™; a microarray patch (MAP) for child immunization in low and middle-income countriesElise Guillermet, Daleb Abdoulaye Alfa, Le Thi Phuong Mai, et al.
Infection and Immunity|October 10, 2007
In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunizedKazutoyo Miura, Hong Zhou, Olga V Muratova, et al.
Pageof 5